bufuralol has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balant, L; Fabre, J; Francis, RJ; Marmy, A; Tozer, TN; Tschopp, JM | 1 |
| Balant, LP; Dayer, P; Fabre, J | 1 |
| Balant, L | 1 |
2 review(s) available for bufuralol and Kidney Diseases
| Article | Year |
|---|---|
Consequences of renal insufficiency on the hepatic clearance of some drugs.
Topics: Adrenergic beta-Antagonists; Biotransformation; Dextropropoxyphene; Ethanolamines; Humans; Kidney Diseases; Kidney Failure, Chronic; Kinetics; Liver; Models, Biological; Oxprenolol; Pharmaceutical Preparations; Propanolamines; Propranolol; Renal Dialysis | 1983 |
Applicability of different types of models in health and disease.
Topics: Disease; Ethanolamines; Excipients; Genetic Diseases, Inborn; Health; Humans; Kidney Diseases; Kinetics; Models, Biological; Pharmaceutical Preparations; Phenotype; Xylose | 1984 |
1 other study(ies) available for bufuralol and Kidney Diseases
| Article | Year |
|---|---|
Influence of renal failure on the hepatic clearance of bufuralol in man.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ethanolamines; Female; Humans; Kidney; Kidney Diseases; Kinetics; Liver; Male; Mathematics; Metabolic Clearance Rate; Middle Aged | 1980 |